SLC5A2 and Insulin resistance: Our study suggests that targeting mitochondrial dysfunction in PCOS may be necessary to improve insulin resistance and that hyperandrogenemia blunts the beneficial effect of SGLT2 inhibitors in the HAF rat model of PCOS.